First CE-IVD marked AI solution for prognostic risk stratification of breast cancer patients.
Stratipath, a global leader in AI-based precision diagnostic solutions, today announced that its AI software for prognostic risk stratification of breast cancers, Stratipath Breast, is now CE-IVD marked. Stockholm, Sweden, June 01, 2022 (GLOBE NEWSWIRE) — Stratipath, a global leader in AI-based precision diagnostic solutions, today announced that its AI